الفهرس | Only 14 pages are availabe for public view |
Abstract Background: COVID-19 is one of the sever acute respiratory syndrome, it can have an impact on a person‘s physical, psychological, and social well-being Along with respiratory illness , profound pro thrombotic milieu leading to both arterial and venous thrombosis .These patients are primarily managed with anticoagulant drugs combined with circulatory exercises. Aim of the study: Finding out if there was effect of low level laser therapy on hypercoagulability in patients with Covid-19. Methods: Sixty patients with COVID-19 both gender, their ages ranged from 35 to 45 years. The participants were selected from EL-Men showy general hospital, Tanta governorate, Egypt randomly assigned into two groups equal in number .The experimental group (A) received a program of low intensity laser therapy three times per week for two months, circulatory exercises, and medical treatment, and the control group (B) received circulatory exercises and medical treatment. Demographic data were collected as marital status, level of income, level of education, and occupation. Results: after 12 weeks of intervention in both groups A and B demonstrated significance decrease in D- dimer , fibrinogen , creactive protein , platelet count, prothrombin time , activated partial thromboplastin time , and increase lymphocyte count the best is group A the experimental group rather than group B the control group. Conclusion: It was concluded from the study that LLLT combined with circulatory exercises is beneficial for protection from hypercoagulability in patients with COVID-19. |